Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00448422 | Safety and Efficacy of Prulifloxacin vs Placebo in Treatment of Acute Gastroenteritis in Adult Travelers | PHASE3 | COMPLETED | 268 | — | — | Dec 1, 2006 | Aug 1, 2008 | Sep 27, 2010 | 1 | India |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Tablet |
| 2 | PLACEBO_COMPARATOR | Tablet |
| Name | Type | Description |
|---|---|---|
| prulifloxacin | DRUG | Tablet |
Inclusion Criteria: * Diagnosis of acute bacterial gastroenteritis * Traveler from an industrialized country * Capable of giving Informed Consent Exclusion Criteria: * Fever (\>100.3 degrees) * Pregnant or Breast Feeding or Not using adequate birth control * Known or Suspected (co-)Infection with...